National Cancer Institute Formulary: A Public-Private Partnership Providing Investigators Access to Investigational Anticancer Agents.

Autor:	Cristofaro, JV, Ansher, SS, Zwiebel, JA, Ivy, P, Conley, B, Abrams, JS, Doroshow, JH
Předmět:	DRUG formularies ANTINEOPLASTIC agents PUBLIC-private sector cooperation DRUG accessibility
Zdroj:	Clinical Pharmacology & Therapeutics; May2017, Vol. 101 Issue 5, p616-618, 3p
Abstrakt:	As part of the White House Cancer Moonshot Initiative, the National Cancer Institute (NCI) has developed a drug formulary to provide investigational anticancer agents to the extramural research community. This article describes how the NCI Formulary functions, how researchers may apply for access to drugs in the formulary, and the NCI's initial goals for formulary participation. Approved investigators may apply for access to formulary agents at: . [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text